Mediation analysis demonstrated that 82.8% of steatosis improvement, 71.6% of ballooning reduction, and 69.3% of MASH resolution were attributed to weight loss, while only 25.1% of the fibrosis benefit was weight-related, indicating that other mechanisms other than weight loss may also play a role in the histological improvements associated with semaglutide
Weight regain is common if you stop without maintaining the habits (calorie control, protein intake, training) that support weight maintenance
Qu'est-ce que le smaglutide
For manufacturers, the potential for this wider therapeutic use is worth billions of dollars
According to an obesity specialist at Northwestern Medicine in Chicago, many patients find it challenging to afford the hefty monthly expense of $1,300, particularly for a medication they must take long-term